Neuroscientific Biopharmaceuticals Ltd has released a press release.
Half Yearly Report and Accounts
Earlier from Neuroscientific Biopharmaceuticals
- Quarterly Activities/Appendix 4C Cash Flow Report
- Successful Clinical Results Achieved under Special Access
- Trading Halt
- Fourth Patient Commences StemSmart MSC Treatment